Jazz Pharmaceuticals Inc

Type: Company
Name: Jazz Pharmaceuticals Inc
First reported 23 hours ago - Updated 2 hours ago - 2 reports

Jazz Pharmaceuticals (JAZZ) Showing Resistance Near $166.32

After Thursday’s trading in Jazz Pharmaceuticals Inc. (JAZZ) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 7.72% or 30.64% (for comparison purposes only), while providing 9.01% downside protection. The ... [Published MarketIntelligenceCenter.com - 2 hours ago]
First reported 15 hours ago - Updated 14 hours ago - 1 reports

Five Leading International Stocks Near Buy Points

Half of the stocks on IBD's Top 10 World Stocks are in buying range or otherwise near buy points.In buying range means a stock has passed a buy point , but is not yet extended 5% from it. Investors should buy before a stock rises 5% beyond a buy poin ... [Published Investor's Business Daily - 15 hours ago]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Al Franken ad targets Mike McFadden's business background

U.S. Sen. Al Franken continued his attack Wednesday on challenger Mike McFadden's business background, releasing an ad criticizing McFadden's firm's involvement in a 2012 corporate inversion that moved an American firm to Ireland and dropped its tax ... [Published TwinCities.com - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Jazz Pharmaceuticals (JAZZ) Trading Near $153.90 Support Level

After Tuesday’s trading in Jazz Pharmaceuticals Inc. (JAZZ) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 7.13% or 27.69% (for comparison purposes only), while providing 9.13% downside protection. The trade ... [Published MarketIntelligenceCenter.com - Sep 17 2014]
First reported Sep 13 2014 - Updated Sep 13 2014 - 1 reports

Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

Biotech and pharmaceutical companies are on the rise with life-saving promises, adding to hopes that their stocks will also be healthy investments.The industry was down Friday on general market weakness and concerns over growth stocks. But it continues ... [Published Investor's Business Daily - Sep 13 2014]
First reported Sep 13 2014 - Updated Sep 13 2014 - 1 reports

A Tale Of Two Portfolios

By Tony Pow : The first portfolio (20 stocks) was described in my SA article Amazing Returns more than a year ago and the second portfolio (15 stocks) ... Related Stocks: ADVANCED EMISSIONS ALCATEL-LUCENT AROTECH Apple Inc. CANADIAN SOLAR CATERPILLAR, ... [Published Chicago Daily Herald - Sep 13 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Jazz Pharmaceuticals (JAZZ) Showing Support Near $166.48

Wednesday’s trading in Jazz Pharmaceuticals Inc. (JAZZ) gives options traders an opportunity for a 13.12% return. By selling the Dec. '14 $170.00 call and buying the Jan. '16 call at the $95.00 level for a net debit of $66.30, traders will book a profit ... [Published MarketIntelligenceCenter.com - Sep 11 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 2 reports

Jazz Pharmaceuticals Up on Allergan Takeover Buzz

Shares of Jazz Pharmaceuticals jumped as much as 7 percent Friday on rumours of a potential takeover by Allergan, Orange County Business Journal reported. Allergan is attempting to resist a takeover by Valeant Pharmaceuticals and Allergan shareholder ... [Published FirstWord Pharma - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 2 reports

Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

The new buys list of top-performing funds the past three months showed some heavy buying of top-rated stocks. The nation's leading funds have been stocking up on medical issues, which fared well as the market resumed its uptrend in August. Large heavy-hitting ... [Published Town Hall - Sep 03 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 3 reports

Jazz Pharmaceuticals joins AstraZeneca and Lilly on Box's client list

Jazz Pharmaceuticals ($JAZZ) and Boston Scientific ( $BSX ) have begun using Box as their main platform for managing and collaborating on content. The companies join AstraZeneca ( $AZN ), Eli Lilly ( $LLY ) and Edwards Lifesciences on Box's list of life ... [Published Fierce Biotech IT - Aug 25 2014]
First reported Aug 20 2014 - Updated Aug 21 2014 - 4 reports

BOSTON SCIENTIFIC : Box Powers Cloud Collaboration for Leading Life Sciences Organizations

"Pharmaceutical and life sciences companies have a tremendous opportunity to move critical business content like research materials and findings to the cloud, dramatically improving internal and external processes and increasing the speed and flow of ... [Published 4 Traders - Aug 21 2014]
First reported Aug 20 2014 - Updated Aug 21 2014 - 2 reports

Boston Scientific to deploy Box through AT

August 21, 2014 Written byPrintEmailBoston Scientific is partnering with Box, AT&T to deliver cloud storage services to its 23,000 employees globallyUS-based pharmaceuticals firm Boston Scientific Corporation announced plans to deploy Box’s as the company’s ... [Published Business Cloud News - Aug 21 2014]

Quotes

After closing Wednesday at $162.30, Jazz Pharmaceuticals Inc. (http://www.marketintelligencecenter.com/symbol/JAZZ "JAZZ) presents an attractive opportunity to get a 8.04% return in just 93 days, which is an annualized return of 31.54% (for comparison purposes only). To enter this trade, sell one Dec. '14 $160.00 call for each 100 shares of JAZZ for a net debit of about $148.10. The net debit for this trade is also the break even point, which means this position has 8.75% downside protection."
"Another embodiment of the present invention is a method of administering GHB to a patient in need thereof, comprising administering to the patient a therapeutically effective amount of GHB while avoiding concomitant administration of diclofenac or valproate."

More Content

All (279) | News (117) | Reports (0) | Blogs (149) | Audio/Video (0) | Fact Sheets (0) | Press Releases (12)
sort by: Date | Relevance
Jazz Pharmaceuticals (JAZZ) Showing Resistance ... [Published MarketIntelligenceCenter.com - 2 hours ago]
Five Leading International Stocks Near Buy Points [Published Investor's Business Daily - 15 hours ago]
Potential Jazz Pharmaceuticals (JAZZ) Trade Has... [Published Individual.com - 23 hours ago]
Wall Street's Latest Tax Craze... And How To Pr... [Published Yahoo! Finance - 23 hours ago]
Potential Jazz Pharmaceuticals (JAZZ) Trade Has... [Published MarketIntelligenceCenter.com - Sep 18 2014]
Patent Application Titled "Method of Administra... [Published 4 Traders - Sep 17 2014]
Al Franken ad targets Mike McFadden's business ... [Published TwinCities.com - Sep 17 2014]
Jazz Pharmaceuticals (JAZZ) Trading Near $153.9... [Published MarketIntelligenceCenter.com - Sep 17 2014]
Should You Invest in Corporate Tax Inversions? [Published Motley Fool Discussion Boards - Sep 17 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Sep 16 2014]
Jazz Pharmaceuticals plc – CMO Jeffrey K. Tobia... [Published American Banking News - Sep 16 2014]
Insider Selling: Jazz Pharmaceuticals plc – Dir... [Published American Banking News - Forex - Sep 16 2014]
Insider Selling: Karen J. Wilson Sells 3,000 Sh... [Published American Banking News - Sep 16 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Sep 15 2014]
Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers [Published Investor's Business Daily - Sep 13 2014]
A Tale Of Two Portfolios [Published Chicago Daily Herald - Sep 13 2014]
A Tale Of Two Portfolios [Published Seeking Alpha - Sep 13 2014]
The Best Pharma ETF [Published BioPortfolio - Sep 12 2014]
Jazz Pharmaceuticals plc – Receives Average Rec... [Published American Banking News - Forex - Sep 12 2014]
Shares of JAZZ Up 16.1% Since Uptrend Call on S... [Published Individual.com - Sep 12 2014]
Potential Jazz Pharmaceuticals (JAZZ) Trade Has... [Published MarketIntelligenceCenter.com - Sep 12 2014]
Alize Pharma raises EUR 5 million (USD 6.6 mill... [Published Tornado Insider - Sep 12 2014]
Jazz Pharmaceuticals (JAZZ) Showing Support Nea... [Published MarketIntelligenceCenter.com - Sep 11 2014]
Alize Pharma raises EUR 5 million (USD 6.6 mill... [Published MENAFN - Sep 11 2014]
Potential Jazz Pharmaceuticals (JAZZ) Trade Has... [Published MarketIntelligenceCenter.com - Sep 10 2014]
Jazz Pharmaceuticals (JAZZ) Trading Near $163.8... [Published MarketIntelligenceCenter.com - Sep 09 2014]
Jazz Pharmaceuticals In Buy Range Amid Takeover... [Published Industrial Info Financials - Sep 08 2014]
Court Report - September 2014 [Published JD Supra - Sep 08 2014]
Why Ariad Pharmaceuticals, Inc. Stock Plunged 1... [Published Motley Fool Discussion Boards - Sep 08 2014]
Potential Jazz Pharmaceuticals (JAZZ) Trade Has... [Published Individual.com - Sep 08 2014]
1 2 3 4 5 6 7 8 9 10
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Jazz Pharmaceuticals (JAZZ) Showing Resistance ... [Published MarketIntelligenceCenter.com - 2 hours ago]
After Thursday’s trading in Jazz Pharmaceuticals Inc. (JAZZ) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 7.72% or 30.64% (for comparison purposes only), while providing 9.01% downside protection. The ...
Potential Jazz Pharmaceuticals (JAZZ) Trade Has... [Published MarketIntelligenceCenter.com - Sep 18 2014]
After closing Wednesday at $162.30, Jazz Pharmaceuticals Inc. (JAZZ) presents an attractive opportunity to get a 8.04% return in just 93 days, which is an annualized return of 31.54% (for comparison purposes only). To enter this trade, sell one Dec. '14 ...
Jazz Pharmaceuticals (JAZZ) Trading Near $153.9... [Published MarketIntelligenceCenter.com - Sep 17 2014]
After Tuesday’s trading in Jazz Pharmaceuticals Inc. (JAZZ) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 7.13% or 27.69% (for comparison purposes only), while providing 9.13% downside protection. The trade ...
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Sep 16 2014]
Jazz Pharmaceuticals Inc. (JAZZ) traded between $156.79 and $168.39 before closing at $160.35 Monday and presents some attractive trading opportunities today. MarketIntelligenceCenter.com’s algorithms have picked a Dec. '14 $160.00 covered call for a ...
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Sep 15 2014]
Friday’s trading in Jazz Pharmaceuticals Inc. (JAZZ) gives options traders an opportunity for a 11.19% return. By selling the Dec. '14 $165.00 call and buying the Jan. '16 call at the $85.00 level for a net debit of $71.95, traders will book a profit ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Jazz Pharmaceuticals Announces Pricing of $500 ... [Published Financial Services - Aug 08 2014]
The Zacks Analyst Blog Highlights: Medtronic, C... [Published Financial Services - Aug 01 2014]
Financial Results, Clinical Trial Initiations, ... [Published Financial Services - Jul 30 2014]
Biotech Companies Release Quarterly Financials ... [Published Financial Services - Jul 29 2014]
The Zacks Analyst Blog Highlights:Regado Biosci... [Published Financial Services - Jul 10 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.